ARCHIVES

US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.

This article is from The Cancer Letter archive.

Vol. 26 No. 30 | July 28, 2000

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group Clinical Trials Approved

April 30, 2010

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001

Clinical Trials: Breast Cancer Prevention Trial requires Fewer Participants, NCI Says

September 6, 1996

Research Contracts Branch Reorganized, Graalman On “Detail”

October 22, 1982

The Cancer Letter Obtains “Confidential” Documents From Duke IRB Investigation

May 14, 2010

Alan Rabson Outlasts Them All, Even His Bosses, As DCBD Chief

January 15, 1982